J&J revamps drug research, plots medical device deals

By The Wall Street Journal
| September 14, 2023

The company launches rebranding as it focuses on prescription drugs and medical devices after shedding consumer business.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

One of the most important elements of a company’s success is also one of the least tangible —culture. ...